0000000000341317

AUTHOR

Yan Shen

showing 2 related works from this author

Diketopyrrolopyrrole based D-π-A-π-D type small organic molecules as hole transporting materials for perovskite solar cells

2018

Abstract Three novel diketopyrrolopyrrole (DPP) based small organic molecules were synthesized as hole transporting materials for perovskite solar cells. The effects of different donors and π bridges on the performance of perovskite solar cells (PSCs) were discussed. The efficiency of TPADPP-1, TPADPP-2, PTZDPP-2 was 5.10%, 9.85% and 8.16% respectively. Compared to TPADPP-2, the voltage of PTZDPP-2 was higher. Because the electron-donating ability of phenothiazine based donor was larger than that of triphenylamine based donor, the HOMO level of PTZDPP-2 was lower than that of TPADPP-2. The results indicated that the diketopyrrolopyrrole based D-π-A-π-D type small organic molecule might be a…

Materials scienceInorganic chemistryEnergy Engineering and Power Technology02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnologyPhotochemistryTriphenylamine01 natural sciences0104 chemical sciencesOrganic moleculeschemistry.chemical_compoundFuel TechnologychemistryPhenothiazineElectrochemistryMolecule0210 nano-technologyEnergy (miscellaneous)Perovskite (structure)Journal of Energy Chemistry
researchProduct

Determinants of Quality of Life According to Cognitive Status in Parkinson’s Disease

2020

Background: Quality of life (QoL) was worse in Parkinson's disease patients with mild cognitive impairment (PD-MCI) or dementia (PDD) than PD patients with normal cognition (PD-NC). The aim of this study was to investigate and compare the potential heterogeneous determinants of QoL in PD patients with different cognitive statuses. Methods: We recruited 600 PD patients, including 185 PD-NC patients, 336 PD-MCI patients and 79 PDD patients, in this cross-sectional study. All patients completed the QoL assessment by the 39-item Parkinson's Disease Questionnaire (PDQ-39), as well as clinical evaluations and neuropsychological tests. The determinants of the QoL were analysed by multiple stepwise…

0301 basic medicineAgingmedicine.medical_specialtyParkinson's diseaseCognitive NeuroscienceDiseasebehavioral disciplines and activitieslcsh:RC321-57103 medical and health sciences0302 clinical medicinemild cognitive impairmentQuality of lifeRating scalemental disordersmedicineDementialcsh:Neurosciences. Biological psychiatry. NeuropsychiatryDepression (differential diagnoses)Original Researchbusiness.industryNeuropsychologyCognitiondeterminantsmedicine.diseasehumanitiesnervous system diseases030104 developmental biologyquality of lifePhysical therapyParkinson’s diseasebusinesshuman activities030217 neurology & neurosurgeryNeurosciencedementiaFrontiers in Aging Neuroscience
researchProduct